Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03118466
Brief Title: Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia

First Submitted : March 30, 2017
First Submitted that Met QC Criteria : April 17, 2017
First Posted : April 18, 2017

Results First Submitted : January 13, 2021
Results First Submitted that Met QC Criteria : January 13, 2021
Results First Posted : February 3, 2021

Last Update Submitted that Met QC Criteria : January 13, 2021
Last Update Posted : February 3, 2021